# | Title | Journal | Year | Citations |
---|
1 | Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use | Journal of Clinical Pharmacology | 2005 | 1,110 |
2 | A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs | Journal of Clinical Pharmacology | 1984 | 749 |
3 | The Anticholinergic Drug Scale as a Measure of Drug-Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity | Journal of Clinical Pharmacology | 2006 | 521 |
4 | Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans | Journal of Clinical Pharmacology | 2001 | 510 |
5 | A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals | Journal of Clinical Pharmacology | 2002 | 492 |
6 | DHEA and DHEA-S: A Review | Journal of Clinical Pharmacology | 1999 | 451 |
7 | Global Burden of Disease (GBD) for Hepatitis C | Journal of Clinical Pharmacology | 2004 | 429 |
8 | Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi) | Journal of Clinical Pharmacology | 2010 | 423 |
9 | Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis | Journal of Clinical Pharmacology | 2005 | 411 |
10 | Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers | Journal of Clinical Pharmacology | 2010 | 392 |
11 | Cannabidiol: An Overview of Some Pharmacological Aspects | Journal of Clinical Pharmacology | 2002 | 385 |
12 | Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans | Journal of Clinical Pharmacology | 2010 | 345 |
13 | New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process | Journal of Clinical Pharmacology | 2008 | 333 |
14 | Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Bone Metastases | Journal of Clinical Pharmacology | 2002 | 329 |
15 | Effects of Celecoxib, a Novel Cyclooxygenase-2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial | Journal of Clinical Pharmacology | 2000 | 328 |
16 | Nuclear Receptors and the Regulation of Drug-Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs | Journal of Clinical Pharmacology | 2007 | 328 |
17 | Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma | Journal of Clinical Pharmacology | 1996 | 321 |
18 | Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target | Journal of Clinical Pharmacology | 1998 | 315 |
19 | Origin and Uses ofPrimum Non Nocere-Above All, Do No Harm! | Journal of Clinical Pharmacology | 2005 | 311 |
20 | Dose‐Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in Humans | Journal of Clinical Pharmacology | 1997 | 309 |
21 | Body Weight Has Limited Influence on the Safety, Tolerability, Pharmacokinetics, or Pharmacodynamics of Rivaroxaban (BAY 59-7939) in Healthy Subjects | Journal of Clinical Pharmacology | 2007 | 303 |
22 | Stability and Performance of a Population Pharmacokinetic Model | Journal of Clinical Pharmacology | 1997 | 302 |
23 | Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis | Journal of Clinical Pharmacology | 1995 | 287 |
24 | Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous Administration | Journal of Clinical Pharmacology | 1996 | 285 |
25 | Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects | Journal of Clinical Pharmacology | 2002 | 283 |
26 | Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled Study | Journal of Clinical Pharmacology | 1993 | 278 |
27 | Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel | Journal of Clinical Pharmacology | 2008 | 274 |
28 | Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro Models | Journal of Clinical Pharmacology | 2001 | 261 |
29 | Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX‐2 versus COX‐1 in Healthy Volunteers | Journal of Clinical Pharmacology | 2000 | 261 |
30 | Cardiovascular System Effects of Marijuana | Journal of Clinical Pharmacology | 2002 | 260 |
31 | Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches | Journal of Clinical Pharmacology | 2009 | 260 |
32 | Nonsteroidal Anti‐Inflammatory Drugs: Effects on Kidney Function | Journal of Clinical Pharmacology | 1991 | 256 |
33 | Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement | Journal of Clinical Pharmacology | 2005 | 256 |
34 | Efficacy of Antidepressants as Analgesics: A Review | Journal of Clinical Pharmacology | 2012 | 254 |
35 | Hemodynamic Response to the Upright Posture | Journal of Clinical Pharmacology | 1994 | 253 |
36 | Effects of Tolterodine, Trospium Chloride, and Oxybutynin on the Central Nervous System | Journal of Clinical Pharmacology | 2001 | 236 |
37 | Microbial Biofilms: Their Development and Significance for Medical Device-Related Infections | Journal of Clinical Pharmacology | 1999 | 232 |
38 | Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir | Journal of Clinical Pharmacology | 1998 | 228 |
39 | The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective | Journal of Clinical Pharmacology | 2003 | 228 |
40 | Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test Abnormalities | Journal of Clinical Pharmacology | 2006 | 228 |
41 | Pharmacokinetics of Lenalidomide in Subjects With Various Degrees of Renal Impairment and in Subjects on Hemodialysis | Journal of Clinical Pharmacology | 2007 | 224 |
42 | Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis | Journal of Clinical Pharmacology | 2016 | 224 |
43 | Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers | Journal of Clinical Pharmacology | 2000 | 221 |
44 | Effect of Food, an Antacid, and the H2Antagonist Ranitidine on the Absorption of BAY 59-7939 (Rivaroxaban), an Oral, Direct Factor Xa Inhibitor, in Healthy Subjects | Journal of Clinical Pharmacology | 2006 | 220 |
45 | Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function | Journal of Clinical Pharmacology | 2003 | 219 |
46 | Safety, Tolerability, and Pharmacokinetics of PTC124, a Nonaminoglycoside Nonsense Mutation Suppressor, Following Single- and Multiple-Dose Administration to Healthy Male and Female Adult Volunteers | Journal of Clinical Pharmacology | 2007 | 218 |
47 | Analgesic Effect of Delta‐9‐Tetrahydrocannabinol | Journal of Clinical Pharmacology | 1975 | 216 |
48 | Pharmacokinetic and Pharmacodynamic Consequences of Metabolism‐Based Drug Interactions with Alprazolam, Midazolam, and Triazolam | Journal of Clinical Pharmacology | 1999 | 216 |
49 | Hypnotic and Antiepileptic Effects of Cannabidiol | Journal of Clinical Pharmacology | 1981 | 214 |
50 | Concentration‐QT Relationships Play a Key Role in the Evaluation of Proarrhythmic Risk During Regulatory Review | Journal of Clinical Pharmacology | 2008 | 206 |